Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)

NCT00703365 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG: Sorafenib and Gemcitabine

Sponsor

Mahidol University

Collaborators

[object Object]
[object Object]
[object Object]